Key points are not available for this paper at this time.
N+AVD resulted in longer progression-free survival than BV+AVD in adolescents and adults with stage III or IV advanced-stage classic Hodgkin's lymphoma and had a better side-effect profile. (Funded by the National Cancer Institute of the National Institutes of Health and others; S1826 ClinicalTrials.gov number, NCT03907488.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Alex F. Herrera
City Of Hope National Medical Center
Michael LeBlanc
Fred Hutch Cancer Center
Sharon M. Castellino
Children's Healthcare of Atlanta
New England Journal of Medicine
Cornell University
City of Hope
Building similarity graph...
Analyzing shared references across papers
Loading...
Herrera et al. (Wed,) studied this question.
synapsesocial.com/papers/69d763a35f9a1dad5349004d — DOI: https://doi.org/10.1056/nejmoa2405888
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: